| __timestamp | Agios Pharmaceuticals, Inc. | Celldex Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 100371000 | 104381000 |
| Thursday, January 1, 2015 | 141827000 | 100171000 |
| Friday, January 1, 2016 | 220163000 | 102726000 |
| Sunday, January 1, 2017 | 292681000 | 96171000 |
| Monday, January 1, 2018 | 341324000 | 66449000 |
| Tuesday, January 1, 2019 | 410894000 | 42672000 |
| Wednesday, January 1, 2020 | 367470000 | 42534000 |
| Friday, January 1, 2021 | 256973000 | 53311000 |
| Saturday, January 1, 2022 | 279910000 | 82258000 |
| Sunday, January 1, 2023 | 288903000 | 118011000 |
| Monday, January 1, 2024 | 301286000 |
Unleashing insights
In the competitive world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Agios Pharmaceuticals, Inc. and Celldex Therapeutics, Inc. have shown contrasting approaches over the past decade. From 2014 to 2023, Agios consistently outspent Celldex, with its R&D expenses peaking in 2019 at nearly four times that of Celldex. While Agios's R&D spending saw a decline post-2019, it still maintained a significant lead, investing approximately 2.9 times more than Celldex in 2023. This trend highlights Agios's aggressive pursuit of innovation, while Celldex's more conservative spending suggests a different strategic focus. As the biotech landscape evolves, these spending patterns may influence their future breakthroughs and market positions.
Analyzing R&D Budgets: Merck & Co., Inc. vs Celldex Therapeutics, Inc.
Research and Development Investment: Amgen Inc. vs Celldex Therapeutics, Inc.
argenx SE or Celldex Therapeutics, Inc.: Who Invests More in Innovation?
Incyte Corporation vs Agios Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Comparing Innovation Spending: Viatris Inc. and Celldex Therapeutics, Inc.
R&D Spending Showdown: Madrigal Pharmaceuticals, Inc. vs Agios Pharmaceuticals, Inc.
R&D Spending Showdown: Axsome Therapeutics, Inc. vs Agios Pharmaceuticals, Inc.
R&D Spending Showdown: MorphoSys AG vs Agios Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: HUTCHMED (China) Limited vs Celldex Therapeutics, Inc.
Soleno Therapeutics, Inc. vs Agios Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
R&D Insights: How Agios Pharmaceuticals, Inc. and Wave Life Sciences Ltd. Allocate Funds
Comparing Innovation Spending: Celldex Therapeutics, Inc. and MiMedx Group, Inc.